Mark Nixon

机构：The Queen's Medical Research Institute, University of Edinburgh · ORCID：0000-0001-5437-3724

发表论文 68 篇 · 总被引 1195 次 · h-index 18

代表论文

• Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment (2023 · RMD Open · 被引 36)
• The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action (2022 · Nature Reviews Endocrinology · 被引 36)
• High salt intake activates the hypothalamic–pituitary–adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice (2022 · Cardiovascular Research · 被引 25)
• Corticosteroid-binding Globulin (SERPINA6) Establishes Postpubertal Sex Differences in Rat Adrenal Development (2022 · Endocrinology · 被引 16)
• ABCC1 modulates negative feedback control of the hypothalamic-pituitary-adrenal axis in vivo in humans (2022 · Metabolism · 被引 16)
• Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16) (2024 · Journal of Patient-Reported Outcomes · 被引 15)